CLINICAL_TRIALS
withdrawal
· 2022-11-08
Clinical Trial Update: Nitropaste in Breast Reduction [Phase 3]
Summary
Phase 3 trial of Nitropaste for gynecomastia and delayed wound healing was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Gynecomastia, Delayed Wound Healing | Phase 3 | Status: WITHDRAWN